Performance evaluation of newly developed fluorescence immunoassay-based interferon-gamma release assay for the diagnosis of latent tuberculosis infection in healthcare workers

J Microbiol Immunol Infect. 2021 May 29:S1684-1182(21)00104-3. doi: 10.1016/j.jmii.2021.05.007. Online ahead of print.ABSTRACTThe ichroma™ IGRA-TB (Boditech Med Inc., Chuncheon, Republic of Korea) is an automated fluorescent immunoassay-based point-of-care interferon-gamma release assay for detecting latent tuberculosis infection. We evaluated this assay with 408 health care workers, and demonstrated its acceptable performances comparing to QuantiFERON-TB Gold-Plus (QFT-Plus; Qiagen, Germantown, MD).PMID:34127404 | DOI:10.1016/j.jmii.2021.05.007
Source: Journal of Microbiology, Immunology, and Infection - Category: Microbiology Authors: Source Type: research